[Anti-SARS virus activities of different recombinant human interferons in cell culture system]. 2003

Zhao-jun Duan, and Li-lan Zhang, and Zhi-ping Xie, and Zhi-ai Yu, and Li-ping Zhang, and Bin Zhang, and Yong-qing Liu, and Jian-wei Wang, and Wu-ping Li, and Cheng-hai Zhang, and Xue-jun Ma, and Yue-long Shu, and Shu-min Duan, and De-xin Li, and Yun-de Hou
Beijing Jin Di Ke Biotechnology Institute, State Research Center for Biotechnological Engineering, Beijing 100176, China.

BACKGROUND To study the anti-SARS virus activities of different recombinant human interferons on the cell culture system. METHODS Anti-SARS virus activities of interferons were determined by using CPE inhibition test in human skeletal muscle sarcoma (Rda) cell culture. RESULTS The average minimum amount of interferon alpha 2b, alpha 1b, beta 1b or omega 1b to inhibit 50% CPE in Rda cell culture was (160.5+/-129.5) IU/ml, (149.0+/-71.7) IU/ml, (69.5+/-61.5) IU/ml, (87.3+/-47.1) IU/ml, respectively or (0.6+/-0.5) ng/ml, (10.6+/-5.1) ng/ml, (3.5+/-3.1) ng/ml, (0.9+/-0.5) ng/ml, respectively. CONCLUSIONS All the tested recombinant interferons showed anti-SARS virus activities on the Rda cell culture with different sensitivities.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077190 Interferon alpha-2 Alpha interferon encoded by the human IFNA2 gene. Recombinant forms are used in the treatment of CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; KAPOSI SARCOMA; MELANOMA; and HAIRY CELL LEUKEMIA. IFN-alpha 2,IFN-alpha-2,IFNalpha-2b, Recombinant,Interferon alfa-2a,Interferon alfa-2b,Interferon alpha-2b, Recombinant,Interferon alpha-A,Interferon-alpha 2,Intron A (Interferon),LeIF A,Reaferon,Recombinant Interferon alpha-2a,Recombinant Interferon alpha-2b,Ro 22-8181,Roferon-A,Sch-30500,Viferon,IFNalpha 2b, Recombinant,Interferon alfa 2a,Interferon alfa 2b,Interferon alpha 2,Interferon alpha 2b, Recombinant,Interferon alpha A,Interferon alpha-2a, Recombinant,Recombinant IFNalpha-2b,Recombinant Interferon alpha 2a,Recombinant Interferon alpha 2b,Ro 22 8181,Ro 228181,Roferon A,RoferonA,Sch 30500,Sch30500
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D016898 Interferon-alpha One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways. Interferon Alfa,Interferon, Leukocyte,Interferon, Lymphoblast,alpha-Interferon,IFN-alpha D,IFN-alpha5,Interferon alpha-1,Interferon alpha-17,Interferon alpha-4,Interferon alpha-5,Interferon alpha-7,Interferon alpha-88,Interferon alpha-J,Interferon alpha-T,Interferon alpha4,Interferon alpha5,Interferon, Lymphoblastoid,Interferon, alpha,LeIF I,LeIF J,Leif D,IFN alpha D,IFN alpha5,Interferon alpha,Interferon alpha 1,Interferon alpha 17,Interferon alpha 4,Interferon alpha 5,Interferon alpha 7,Interferon alpha 88,Interferon alpha J,Interferon alpha T,Leukocyte Interferon,Lymphoblast Interferon,Lymphoblastoid Interferon,alpha Interferon
D045169 Severe Acute Respiratory Syndrome A viral disorder characterized by high FEVER, dry COUGH, shortness of breath (DYSPNEA) or breathing difficulties, and atypical PNEUMONIA. A virus in the genus CORONAVIRUS is the suspected agent. Respiratory Syndrome, Severe Acute,Respiratory Syndrome, Acute, Severe,SARS (Severe Acute Respiratory Syndrome)
D045473 Severe acute respiratory syndrome-related coronavirus A species of CORONAVIRUS causing atypical respiratory disease (SEVERE ACUTE RESPIRATORY SYNDROME) in humans. The organism is believed to have first emerged in Guangdong Province, China, in 2002. The natural host is the Chinese horseshoe bat, RHINOLOPHUS sinicus. HCoV-SARS,SARS Virus,SARS-Associated Coronavirus,SARS-CoV,SARS-CoV-1,SARS-like coronavirus,SARSr-CoV,SARSrCoV,Sarbecovirus,Severe Acute Respiratory Syndrome Virus,Severe acute respiratory syndrome coronavirus,SARS Coronavirus,SARS-Related Coronavirus,Urbani SARS-Associated Coronavirus,Coronavirus, SARS,Coronavirus, SARS-Associated,Coronavirus, SARS-Related,Coronavirus, Urbani SARS-Associated,SARS Associated Coronavirus,SARS Related Coronavirus,SARS like coronavirus,SARS-Associated Coronavirus, Urbani,SARS-like coronaviruses,SARSrCoVs,Sarbecoviruses,Severe acute respiratory syndrome related coronavirus,Urbani SARS Associated Coronavirus
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Zhao-jun Duan, and Li-lan Zhang, and Zhi-ping Xie, and Zhi-ai Yu, and Li-ping Zhang, and Bin Zhang, and Yong-qing Liu, and Jian-wei Wang, and Wu-ping Li, and Cheng-hai Zhang, and Xue-jun Ma, and Yue-long Shu, and Shu-min Duan, and De-xin Li, and Yun-de Hou
January 1983, Journal of interferon research,
Zhao-jun Duan, and Li-lan Zhang, and Zhi-ping Xie, and Zhi-ai Yu, and Li-ping Zhang, and Bin Zhang, and Yong-qing Liu, and Jian-wei Wang, and Wu-ping Li, and Cheng-hai Zhang, and Xue-jun Ma, and Yue-long Shu, and Shu-min Duan, and De-xin Li, and Yun-de Hou
May 1977, Infection and immunity,
Zhao-jun Duan, and Li-lan Zhang, and Zhi-ping Xie, and Zhi-ai Yu, and Li-ping Zhang, and Bin Zhang, and Yong-qing Liu, and Jian-wei Wang, and Wu-ping Li, and Cheng-hai Zhang, and Xue-jun Ma, and Yue-long Shu, and Shu-min Duan, and De-xin Li, and Yun-de Hou
November 1991, Journal of virology,
Zhao-jun Duan, and Li-lan Zhang, and Zhi-ping Xie, and Zhi-ai Yu, and Li-ping Zhang, and Bin Zhang, and Yong-qing Liu, and Jian-wei Wang, and Wu-ping Li, and Cheng-hai Zhang, and Xue-jun Ma, and Yue-long Shu, and Shu-min Duan, and De-xin Li, and Yun-de Hou
January 1985, Arzneimittel-Forschung,
Zhao-jun Duan, and Li-lan Zhang, and Zhi-ping Xie, and Zhi-ai Yu, and Li-ping Zhang, and Bin Zhang, and Yong-qing Liu, and Jian-wei Wang, and Wu-ping Li, and Cheng-hai Zhang, and Xue-jun Ma, and Yue-long Shu, and Shu-min Duan, and De-xin Li, and Yun-de Hou
August 2016, Journal of visualized experiments : JoVE,
Zhao-jun Duan, and Li-lan Zhang, and Zhi-ping Xie, and Zhi-ai Yu, and Li-ping Zhang, and Bin Zhang, and Yong-qing Liu, and Jian-wei Wang, and Wu-ping Li, and Cheng-hai Zhang, and Xue-jun Ma, and Yue-long Shu, and Shu-min Duan, and De-xin Li, and Yun-de Hou
January 2004, Scandinavian journal of infectious diseases,
Zhao-jun Duan, and Li-lan Zhang, and Zhi-ping Xie, and Zhi-ai Yu, and Li-ping Zhang, and Bin Zhang, and Yong-qing Liu, and Jian-wei Wang, and Wu-ping Li, and Cheng-hai Zhang, and Xue-jun Ma, and Yue-long Shu, and Shu-min Duan, and De-xin Li, and Yun-de Hou
April 2023, Viruses,
Zhao-jun Duan, and Li-lan Zhang, and Zhi-ping Xie, and Zhi-ai Yu, and Li-ping Zhang, and Bin Zhang, and Yong-qing Liu, and Jian-wei Wang, and Wu-ping Li, and Cheng-hai Zhang, and Xue-jun Ma, and Yue-long Shu, and Shu-min Duan, and De-xin Li, and Yun-de Hou
January 1985, Progress in clinical and biological research,
Zhao-jun Duan, and Li-lan Zhang, and Zhi-ping Xie, and Zhi-ai Yu, and Li-ping Zhang, and Bin Zhang, and Yong-qing Liu, and Jian-wei Wang, and Wu-ping Li, and Cheng-hai Zhang, and Xue-jun Ma, and Yue-long Shu, and Shu-min Duan, and De-xin Li, and Yun-de Hou
May 2019, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
Zhao-jun Duan, and Li-lan Zhang, and Zhi-ping Xie, and Zhi-ai Yu, and Li-ping Zhang, and Bin Zhang, and Yong-qing Liu, and Jian-wei Wang, and Wu-ping Li, and Cheng-hai Zhang, and Xue-jun Ma, and Yue-long Shu, and Shu-min Duan, and De-xin Li, and Yun-de Hou
May 1984, Journal of virology,
Copied contents to your clipboard!